MDT

96.37

+0.09%↑

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Atidarymo kaina

2 -4.31

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

2.1

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Pelno marža	-4,038.095
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+314.69% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1.3M 142M
Ankstesnė atidarymo kaina	6.31
Ankstesnė uždarymo kaina	2

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-30 23:49; UTC

Įsigijimai, susijungimai, perėmimai

WiseTech to Sell Expedient to Appease Competition Regulator

2025-12-30 17:12; UTC

Pagrindinės rinkos jėgos

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

2025-12-30 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-30 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

2025-12-30 21:08; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

2025-12-30 20:41; UTC

Rinkos pokalbiai

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

2025-12-30 20:37; UTC

Uždarbis

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

2025-12-30 19:29; UTC

Rinkos pokalbiai

Corn Extends Pullback in Light Trade -- Market Talk

2025-12-30 18:29; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

2025-12-30 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-30 16:20; UTC

Uždarbis

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

2025-12-30 16:18; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

2025-12-30 16:10; UTC

Rinkos pokalbiai

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

2025-12-30 15:24; UTC

Rinkos pokalbiai

Australian Dollar Could Rise Versus Sterling -- Market Talk

2025-12-30 15:10; UTC

Įsigijimai, susijungimai, perėmimai

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

2025-12-30 14:24; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

2025-12-30 14:22; UTC

Įsigijimai, susijungimai, perėmimai

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

2025-12-30 14:20; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

2025-12-30 14:17; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

2025-12-30 14:16; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

2025-12-30 14:14; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

2025-12-30 14:12; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: Les Editions Croque Futur Is a French Publishing House

2025-12-30 14:10; UTC

Įsigijimai, susijungimai, perėmimai

LVMH Acquires Les Editions Croque Futur

2025-12-30 13:49; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

2025-12-30 13:36; UTC

Rinkos pokalbiai

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

2025-12-30 13:30; UTC

Rinkos pokalbiai

Crude Futures Gain in Light Holiday Trade -- Market Talk

2025-12-30 12:55; UTC

Rinkos pokalbiai

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

2025-12-30 11:55; UTC

Rinkos pokalbiai

Uždarbis

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

2025-12-30 11:47; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

2025-12-30 11:35; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

314.69% į viršų

12 mėnesių prognozė

Vidutinis 8.75 USD 314.69%

Aukščiausias 12 USD

Žemiausias 5.5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.